These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24411591)

  • 1. Treatment for salivary gland hypofunction at both initial and advanced stages of Sjögren-like disease: a comparative study of bone marrow therapy versus spleen cell therapy with a 1-year monitoring period.
    Khalili S; Faustman DL; Liu Y; Sumita Y; Blank D; Peterson A; Kodama S; Tran SD
    Cytotherapy; 2014 Mar; 16(3):412-23. PubMed ID: 24411591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic mice.
    Khalili S; Liu Y; Sumita Y; Maria OM; Blank D; Key S; Mezey E; Tran SD
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1893-9. PubMed ID: 20732442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of Sjogren's-like syndrome in non-obese diabetic mice.
    Tran SD; Kodama S; Lodde BM; Szalayova I; Key S; Khalili S; Faustman DL; Mezey E
    Ann Rheum Dis; 2007 Jun; 66(6):812-4. PubMed ID: 17179174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
    Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
    Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease.
    Khalili S; Liu Y; Kornete M; Roescher N; Kodama S; Peterson A; Piccirillo CA; Tran SD
    PLoS One; 2012; 7(6):e38615. PubMed ID: 22685592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjögren syndrome.
    Baban B; Liu JY; Abdelsayed R; Mozaffari MS
    Exp Mol Pathol; 2013 Dec; 95(3):288-97. PubMed ID: 24060278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.
    Lodde BM; Mineshiba F; Wang J; Cotrim AP; Afione S; Tak PP; Baum BJ
    Ann Rheum Dis; 2006 Feb; 65(2):195-200. PubMed ID: 15975969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
    Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
    Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
    Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability.
    Lodde BM; Mineshiba F; Kok MR; Wang J; Zheng C; Schmidt M; Cotrim AP; Kriete M; Tak PP; Baum BJ
    Oral Dis; 2006 Nov; 12(6):566-72. PubMed ID: 17054769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
    Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
    Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
    Barr JY; Wang X; Kreiger PA; Lieberman SM
    Immunology; 2018 Oct; 155(2):225-237. PubMed ID: 29750331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjögren's syndrome.
    Szyszko EA; Aqrawi LA; Jonsson R; Brokstad KA; Skarstein K
    Autoimmunity; 2016; 49(1):41-9. PubMed ID: 26324998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice.
    Li N; Shigihara T; Tzioufas AG; Notkins AL; Yoon JW; Jun HS
    Arthritis Rheum; 2007 Jul; 56(7):2211-5. PubMed ID: 17599739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of primary Sjögren syndrome].
    Saraux A; Jousse-Joulin S; Devauchelle-Pensec V
    Rev Prat; 2012 Feb; 62(2):234-8. PubMed ID: 22408873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the Submandibular Salivary Gland Epithelial Cell Subpopulations During Progression of Sjögren's Syndrome-Like Disease in the NOD/ShiLtJ Mouse Model.
    Gervais EM; Desantis KA; Pagendarm N; Nelson DA; Enger T; Skarstein K; Liaaen Jensen J; Larsen M
    Anat Rec (Hoboken); 2015 Sep; 298(9):1622-34. PubMed ID: 26179322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome.
    Kok MR; Yamano S; Lodde BM; Wang J; Couwenhoven RI; Yakar S; Voutetakis A; Leroith D; Schmidt M; Afione S; Pillemer SR; Tsutsui MT; Tak PP; Chiorini JA; Baum BJ
    Hum Gene Ther; 2003 Nov; 14(17):1605-18. PubMed ID: 14633403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity].
    He J; Zhao JX; Wang H; Li ZG
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):625-9. PubMed ID: 18646720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.